ANSES, Risk Assessment Department, France.
Univ-Lyon, CarMeN Laboratory, INSERM U1060, INRAE U1397, Université Claude Bernard Lyon 1, France.
Environ Res. 2022 Mar;204(Pt C):112233. doi: 10.1016/j.envres.2021.112233. Epub 2021 Oct 21.
The close structural analogy of bisphenol (BP) S with BPA, a recognized endocrine-disrupting chemical and a substance of very high concern in the European Union, highlights the need to assess the extent of similarities between the two compounds and carefully scrutinize BPS potential toxicity for human health. This analysis aimed to investigate human health toxicity data regarding BPS, to find a point of departure for the derivation of human guidance values. A systematic and transparent methodology was applied to determine whether European or international reference values have been established for BPS. In the absence of such values, the scientific literature on human health effects was evaluated by focusing on human epidemiological and animal experimental studies. The results were analyzed by target organ/system: male and female reproduction, mammary gland, neurobehavior, and metabolism/obesity. Academic experimental studies were analyzed and compared to regulatory data including subchronic studies and an extended one-generation and reproduction study. In contrast to the regulatory studies, which were performed at dose levels in the mg/kg bw/day range, the academic dataset on specific target organs or systems showed adverse effects for BPS at much lower doses (0.5-10 μg/kg bw/day). A large disparity between the lowest-observed-adverse-effect levels (LOAELs) derived from regulatory and academic studies was observed for BPS, as for BPA. Toxicokinetic data on BPS from animal and human studies were also analyzed and showed a 100-fold higher oral bioavailability compared to BPA in a pig model. The similarities and differences between the two bisphenols, in particular the higher bioavailability of BPS in its active (non-conjugated) form and its potential impact on human health, are discussed. Based on the available experimental data, and for a better human protection, we propose to derive human reference values for exposure to BPS from the N(L)OAELs determined in academic studies.
双酚 S(BPS)与双酚 A(BPA)具有密切的结构相似性,BPA 是一种公认的内分泌干扰化学物质,也是欧盟高度关注的物质,这凸显了评估这两种化合物之间相似程度的必要性,并需要仔细审查 BPS 对人类健康的潜在毒性。本分析旨在研究有关 BPS 的人类健康毒性数据,为推导人类指导值提供起点。应用系统透明的方法来确定 BPS 是否已经建立了欧洲或国际参考值。在没有此类值的情况下,通过重点关注人类流行病学和动物实验研究,评估了有关人类健康影响的科学文献。根据目标器官/系统进行分析:男性和女性生殖、乳腺、神经行为和新陈代谢/肥胖。分析并比较了学术实验研究和包括亚慢性研究和扩展一代和生殖研究在内的监管数据。与在 mg/kg bw/day 剂量水平进行的监管研究相反,针对特定目标器官或系统的学术数据集显示 BPS 在低得多的剂量(0.5-10 μg/kg bw/day)下具有不良影响。与 BPA 一样,从监管和学术研究中得出的 BPS 的最低观察到的不良效应水平(LOAEL)之间存在很大差异。还分析了 BPS 的动物和人体毒代动力学数据,结果表明在猪模型中,BPS 的口服生物利用度比 BPA 高 100 倍。讨论了这两种双酚的相似之处和不同之处,特别是 BPS 的活性(非缀合)形式的生物利用度更高及其对人类健康的潜在影响。基于现有的实验数据,为了更好地保护人类,我们建议从学术研究中确定的 N(L)OAEL 来推导 BPS 暴露的人类参考值。